Public Profile

LNK International

LNK International, a prominent player in the global healthcare industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1988, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including over-the-counter medications and dietary supplements. LNK International is renowned for its commitment to innovation and quality, offering unique formulations that cater to diverse consumer needs. With a strong market position, the company has achieved notable milestones, including numerous partnerships with major retailers and a robust portfolio of proprietary brands. LNK International continues to set industry standards, driven by its dedication to enhancing health and wellness worldwide.

DitchCarbon Score

How does LNK International's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

LNK International's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

LNK International's reported carbon emissions

LNK International, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and enhancing sustainability. As the global focus on climate action intensifies, it is essential for companies like LNK International to establish measurable targets and transparent reporting to align with best practices in environmental stewardship.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. LNK International's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for LNK International is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

LNK International is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

NBTY Acquisition, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Perrigo

IE
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Taro Pharmaceutical Industries Ltd.

IL
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

GUARDIAN DRUG

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

P AND L DEVELOPMENT LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers